Literature DB >> 14716114

Stones associated renal pelvic malignancies.

M Raghavendran1, A Rastogi, D Dubey, H Chaudhary, A Kumar, A Srivastava, A Mandhani, N Krishnani, R Kapoor.   

Abstract

BACKGROUND: The clinico-pathological characteristics of renal pelvic malignancies associated with stones were retrospectively analyzed. AIMS: The main objective was to define the biological behavior and prognostic factors for these malignancies. SETTINGS &
DESIGN: The tumors were classified according to the pathological types. The clinical data, imaging features and pathological features were analyzed with relation to prognosis.
MATERIAL AND METHODS: Eighteen cases of malignancies associated with stone disease were retrospectively studied. The institute review board permitted the study.
RESULTS: High incidence (15/18) of squamous cell carcinoma (SCC) was noted. The prognosis in this group of patients was uniformly poor. The median survival time was 3.6 months in the SCC group, 7.5 months in the Transitional Cell Carcinoma (TCC) group and 24 months in the Adenocarcinoma (AC) group. Infectious and systemic symptoms were noted in the majority of the patients. Preoperative Imaging techniques revealed tumor in only 2 cases. Both underwent radical extirpation and the median survival is 18 months till date. In the other 16 patients, where the initial diagnosis was made only on histological analysis of incomplete nephrectomy specimens, the survival was 3.56 months. All patients had prolonged history of staghorn stone disease with associated non-functioning kidney. We found that the main prognostic factor was the stage of the disease.
CONCLUSIONS: Malignancies associated with stone disease have insidious onset of clinical symptoms and need a high degree of suspicion to identify them pre-operatively. The grave prognosis associated with incomplete excision makes it imperative to diagnose them earlier.

Entities:  

Mesh:

Year:  2003        PMID: 14716114

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  8 in total

1.  Transitional cell carcinoma within a calyceal diverticulum associated with stone disease.

Authors:  Jack M Zuckerman; Corey Passman; Dean G Assimos
Journal:  Rev Urol       Date:  2010

2.  Squamous Cell Carcinoma of the Renal Pelvis, A Rare Site for a Commonly Known Malignancy.

Authors:  Murugappan Nachiappan; Manjusha Madhusudhan Litake; Varun Gautam Paravatraj; Navil Sharma; Aditya Narasimhan
Journal:  J Clin Diagn Res       Date:  2016-01-01

3.  Squamous cell carcinoma arising from longstanding colocutaneous fistula: a case report.

Authors:  Yueh-Tsung Lee; Sheng-Der Hsu; Chien-Long Kuo; Dev-Aur Chou; Mao-Sheng Lin; Min-Ho Huang; Hurng-Sheng Wu
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

4.  Spontaneous kidney rupture in a patient on chronic hemodialysis.

Authors:  G Li Cavoli; L Bono; C Tortorici; A Ferrantelli; C Giammarresi; I Di Lorenzo; U Rotolo
Journal:  Indian J Nephrol       Date:  2012-03

5.  Multiple risk markers for atherogenesis associated with chronic inflammation are detectable in patients with renal stones.

Authors:  Kuo-Chien Tsao; Tsu-Lan Wu; Pi-Yueh Chang; Chien-Feng Sun; Lily L Wu; James T Wu
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

6.  Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract.

Authors:  C Langner; G Hutterer; T Chromecki; P Rehak; R Zigeuner
Journal:  Virchows Arch       Date:  2006-03-09       Impact factor: 4.064

7.  Squamous cell carcinoma of the renal pelvis associated with kidney stones: radiologic imaging features with gross and histopathological correlation.

Authors:  Ozlem Tugce Kalayci; Zehra Bozdag; Fitnet Sonmezgoz; Nurhan Sahin
Journal:  J Clin Imaging Sci       Date:  2013-03-29

8.  Squamous Cell Carcinoma of the Renal Pelvis as a Result of Long-Standing Staghorn Calculi.

Authors:  Kamonchanok Jongyotha; Chutintorn Sriphrapradang
Journal:  Case Rep Oncol       Date:  2015-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.